QTX3034 in Patients With KRAS G12D Mutation
Abroad (travel likely)RecruitingPHASE1
Conditions
Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
- UCLA Hematology/Oncology, Los Angeles, California, United States
- Sarah Cannon Research Institute (SCRI), Denver, Colorado, United States
- Yale Cancer Center, New Haven, Connecticut, United States
- Florida Cancer Specialists, Sarasota, Florida, United States
- Moffitt Cancer Center, Tampa, Florida, United States
- NYU Langone Health, New York, New York, United States
- Montefiore Medical Center, The Bronx, New York, United States
- Duke University, Durham, North Carolina, United States
- Stephenson Cancer Center, Oklahoma City, Oklahoma, United States
- SCRI- Nashville, Nashville, Tennessee, United States
- MD Anderson, Houston, Texas, United States
- START San Antonio, LLC, San Antonio, Texas, United States
- University of Utah, Huntsman Cancer Center, Salt Lake City, Utah, United States
- NEXT Oncology Virginia, Fairfax, Virginia, United States